Research LettersGenetic variations in HLA-B region and hypersensitivity reactions to abacavir
References (5)
- et al.
Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir
Clin Ther
(2001) - et al.
Genetic susceptibility to adverse drug reactions
Trends Pharmacol Sci
(2001)
There are more references available in the full text version of this article.
Cited by (743)
Modern immunology is crucial to revealing the biological mechanisms of traditional Chinese medicine
2023, Journal of Traditional Chinese Medical SciencesSkin testing as a biomarker in drug allergy
2023, Annals of Allergy, Asthma and ImmunologyEconomic analysis of pharmacogenetics testing for human leukocyte antigen-based adverse drug reactions
2023, Economic Evaluation in Genomic and Precision MedicinePrevalence of HLA-B*57:01 allele in HIV-positive and HIV-negative population of eastern India: An epidemiological study
2022, Clinical Epidemiology and Global HealthPharmacogenomics of Drug Hypersensitivity: Technology and Translation
2022, Immunology and Allergy Clinics of North AmericaFrom pharmacogenetics to pharmaco-omics: Milestones and future directions
2022, Human Genetics and Genomics Advances
Copyright © 2002 Elsevier Ltd. All rights reserved.